Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / QNRX - Quoin Pharmaceuticals Loss per ADS of -$0.94 beats by $0.41

QNRX - Quoin Pharmaceuticals Loss per ADS of -$0.94 beats by $0.41

Quoin Pharmaceuticals Ltd.
  • Quoin Pharmaceuticals press release ( NASDAQ: QNRX ): Q3 Loss per ADS of -$0.94 beats by $0.41 .
  • Ended Q3 with ~$15.2M in cash and marketable securities.
  • Ongoing clinical study for QRX003 in Netherton Syndrome continues to progress, with a majority of clinical sites now fully open and the remaining sites on target to open in Q4 2022.
  • Q3 total operating expenses $2.3M vs $1.3M.

For further details see:

Quoin Pharmaceuticals Loss per ADS of -$0.94 beats by $0.41
Stock Information
Company Name: Quoin Pharmaceuticals Ltd.
Stock Symbol: QNRX
Market: NASDAQ
Website: quoinpharma.com
Menu
QNRX QNRX Quote QNRX Short QNRX News QNRX Articles QNRX Message Board
Get QNRX Alerts

News, Short Squeeze, Breakout and More Instantly...